Skip to main content
Clinical Trials/NCT04333641
NCT04333641
Completed
Not Applicable

Development of Novel Imaging Markers Predicting the Progression of Abdominal Aortic Aneurysm Using 3D Computed Tomography

Yonsei University1 site in 1 country323 target enrollmentApril 3, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abdominal Aortic Aneurysm (AAA)
Sponsor
Yonsei University
Enrollment
323
Locations
1
Primary Endpoint
Major adverse aorta-related events
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Study purpose: This study will investigate anatomical factors associated with increased risk of major adverse aorta-related event and accelerated growth of abdominal aneurysm based on 3-dimensional analysis of CT images.

Study design: a multicenter single-arm prospective observational study.

Subject: patients with small abdominal aortic aneurysm with maximal diameter of 30-50 mm (n=323)

Methods: Patients diagnosed with small AAA based on CT will be enrolled after considering inclusion and exclusion criteria and prospectively followed clinically and with CT at 1 year.

Primary endpoint: Major adverse aorta-related events (death, aortic rupture, or aneurysm growth >0.4 cm per year) at 1 year

Secondary endpoints: 1) clinical events : death, aortic rupture, aneurysm growth >0.4 cm per year, surgical or endovascular repair 2) Changes in CT parameters of aneurysm: diameter, volume, wall shear stress

Detailed Description

Prospective single-arm multicenter registry

Registry
clinicaltrials.gov
Start Date
April 3, 2020
End Date
April 17, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • abdominal aortic aneurysm with maximum diameter of 30-50 mm

Exclusion Criteria

  • Age \<19 years
  • Serum Cr\> 1.5mg/dL or eGFR\<30 mL/min
  • Known allergic reactions to iodine contrast media
  • Women in pregnancy or women of childbearing age
  • Abdominal aortic aneurysms indicated for endovascular or surgical repair (symptomatic aneurysm or aneurysms with diameter \>5cm)
  • Saccular type aneurysm, infected or inflammatory aneurysm
  • Combined aortic dissection
  • Aneurysms associated with genetic or connective tissue diseases (Marfan syndrome, Shprintzen-Goldberg syndrome, Loeys-Dietz syndrome, Takayasu's arteritis, Behcet's disease)
  • Past history of surgical or endovascular repair of aorta
  • Any surgical or endovascular repair planned within 1 year

Outcomes

Primary Outcomes

Major adverse aorta-related events

Time Frame: 1 year

Composite event of death, aortic rupture, or aneurysm growth \>0.4 cm per year

Secondary Outcomes

  • Number of clinical events(1 year)
  • Change in CT parameter of aneurysm(1 year)

Study Sites (1)

Loading locations...

Similar Trials